RU2014111060A - Лиганды рецептора эстрогена и способы их применения - Google Patents

Лиганды рецептора эстрогена и способы их применения Download PDF

Info

Publication number
RU2014111060A
RU2014111060A RU2014111060/15A RU2014111060A RU2014111060A RU 2014111060 A RU2014111060 A RU 2014111060A RU 2014111060/15 A RU2014111060/15 A RU 2014111060/15A RU 2014111060 A RU2014111060 A RU 2014111060A RU 2014111060 A RU2014111060 A RU 2014111060A
Authority
RU
Russia
Prior art keywords
alkyl
compound
aryl
membered
haloalkyl
Prior art date
Application number
RU2014111060/15A
Other languages
English (en)
Russian (ru)
Inventor
Джеймс Т. Долтон
Митчелл С. Стейнер
Кристофер С. КОСС
Original Assignee
Джи Ти Икс, ИНК.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/215,679 external-priority patent/US9427418B2/en
Application filed by Джи Ти Икс, ИНК. filed Critical Джи Ти Икс, ИНК.
Priority claimed from PCT/US2012/052141 external-priority patent/WO2013043304A1/en
Publication of RU2014111060A publication Critical patent/RU2014111060A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
RU2014111060/15A 2011-08-23 2012-08-23 Лиганды рецептора эстрогена и способы их применения RU2014111060A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/215,679 US9427418B2 (en) 2009-02-23 2011-08-23 Estrogen receptor ligands and methods of use thereof
US13/215,679 2011-08-23
PCT/US2012/052141 WO2013043304A1 (en) 2009-02-23 2012-08-23 Estrogen receptor ligands and methods of use thereof

Publications (1)

Publication Number Publication Date
RU2014111060A true RU2014111060A (ru) 2015-09-27

Family

ID=48444651

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014111060/15A RU2014111060A (ru) 2011-08-23 2012-08-23 Лиганды рецептора эстрогена и способы их применения

Country Status (10)

Country Link
EP (1) EP2747562A4 (cg-RX-API-DMAC7.html)
JP (1) JP2014524479A (cg-RX-API-DMAC7.html)
KR (1) KR20140064906A (cg-RX-API-DMAC7.html)
CN (1) CN103957706A (cg-RX-API-DMAC7.html)
AU (1) AU2012312902B2 (cg-RX-API-DMAC7.html)
CA (1) CA2845890A1 (cg-RX-API-DMAC7.html)
IL (1) IL231070A0 (cg-RX-API-DMAC7.html)
IN (1) IN2014DN01959A (cg-RX-API-DMAC7.html)
MX (1) MX2014002105A (cg-RX-API-DMAC7.html)
RU (1) RU2014111060A (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3688008A1 (en) * 2017-09-27 2020-08-05 TargImmune Therapeutics AG Castration resistant prostate cancer
SG11202107712SA (en) * 2019-01-30 2021-08-30 Aragon Pharmaceuticals Inc Anti-androgens for the treatment of metastatic castration-sensitive prostate cancer
US20230174662A1 (en) * 2019-02-01 2023-06-08 Fondazione Per L'istituto Oncologico Di Ricerca (Ior) Methods of treating castrate-resistant prostate cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8546451B2 (en) * 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
CA2824517A1 (en) * 2005-11-28 2007-05-31 Gtx, Inc. Nuclear receptor binding agents
US8158828B2 (en) * 2005-11-28 2012-04-17 Gtx, Inc. Nuclear receptor binding agents
WO2010096801A1 (en) * 2009-02-23 2010-08-26 Gtx, Inc. Estrogen receptor ligands and methods of use thereof

Also Published As

Publication number Publication date
EP2747562A4 (en) 2015-05-06
CN103957706A (zh) 2014-07-30
IN2014DN01959A (cg-RX-API-DMAC7.html) 2015-05-15
MX2014002105A (es) 2014-09-25
AU2012312902B2 (en) 2016-03-17
AU2012312902A1 (en) 2013-05-23
JP2014524479A (ja) 2014-09-22
KR20140064906A (ko) 2014-05-28
IL231070A0 (en) 2014-03-31
CA2845890A1 (en) 2013-03-28
EP2747562A1 (en) 2014-07-02

Similar Documents

Publication Publication Date Title
JP6147799B2 (ja) Parpインヒビターとの組合せ療法
RU2011137324A (ru) Лиганды рецепторов эстрогенов и способы их применения
JP2021046418A (ja) コルテキソロン17α−バレレートを含む腫瘍治療に用いるための組成物
AR056155A1 (es) Antagonistas del receptor 1 de la hormona de concentracion de melanina no basica
WO2009148623A2 (en) Methods and related compositions for the treatment of cancer
JP6456383B2 (ja) イソチオシアネート系化合物と抗癌薬の併用
RU2017140674A (ru) Способы лечения рака
NZ631024A (en) Therapies for hematologic malignancies
EP2729144A2 (en) Treating cancer with hsp90 inhibitory compounds
NZ580009A (en) Combination therapies comprising quinoxaline inhibitors of pi3k-alpha for use in the treatment of cancer
JP2010523669A5 (cg-RX-API-DMAC7.html)
RU2014138827A (ru) Антагонисты рецептора андрогена и их применение
WO2012141796A2 (en) Prostate cancer therapy with hsp90 inhibitory compounds
US20150005354A1 (en) Combination Therapy With Parp Inhibitors
RU2014119711A (ru) Трициклические соединения, композиции, содержащие указанные соединения, и их применения
JP2014529584A5 (cg-RX-API-DMAC7.html)
RU2014112320A (ru) Ингибитор pi3k, предназначенный для применения для лечения рака кости или для предупреждения метастатической диссеминации первичных раковых клеток в кость
JP2014524479A5 (cg-RX-API-DMAC7.html)
RU2017105837A (ru) Лечение приливов и потери костной ткани, вызванных андрогенной депривационной терапией, с применением цис-кломифена
RU2006123939A (ru) Лечение остеопороза, связанного с терапией ингибиторами ароматазы
CN107137407B (zh) 一种vegfr抑制剂在制备治疗胰腺癌的药物中的用途
WO2021127305A1 (en) Methods and compositions for inducing apoptosis in cancer stem cells
CA2179377C (en) Method of treatment of hormone-unresponsive metastatic prostate cancer
CN108434137B (zh) 一种治疗前列腺癌的组合物
KR20140064906A (ko) 에스트로겐 수용체 리간드 및 그의 이용 방법

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20161024